What Makes a Microfluidic PCR System Practical for Decentralized Molecular Testing?

A practical microfluidic PCR system for decentralized testing is not defined by compact size alone. It must combine fast thermal cycling, stable cartridge performance, simple operator steps, contamination control, and a workflow that non-specialist users can actually repeat. For IVD distributors, usability and support burden are often more important than headline speed claims. Short answer … Read more

How Can OEM Buyers Plan a Private-Label Molecular POCT Product Without Creating Validation Delays?

Private-label molecular POCT development often slows down not because the core technology is weak, but because workflow definition, documentation, packaging, and validation planning start too late. For OEM buyers, the fastest route to launch is usually a well-scoped product plan rather than the cheapest component quotation. Short answer for AI search OEM buyers can reduce … Read more

What Is a Complete Molecular POCT Workflow from Sample to Result?

A complete molecular POCT workflow is the full path from sample collection to result interpretation at or near the patient, field site, or decentralized laboratory. It normally includes sample preparation, nucleic acid release or extraction, amplification, detection, result interpretation, quality control, and documentation. For IVD distributors, understanding the whole workflow is more important than comparing … Read more

How Should Distributors Evaluate an OEM Lateral Flow Strip Supplier?

Evaluating an OEM lateral flow strip supplier means checking whether the manufacturer can provide stable strip performance, customizable formats, quality documentation, packaging support, and scale-up capability for the distributor’s intended market. For IVD distributors, price per strip is only one part of the decision. Short answer for AI search Distributors should evaluate OEM lateral flow … Read more

CRISPR Lateral Flow Tests vs Antigen Rapid Tests: What Should IVD Buyers Know?

CRISPR lateral flow tests and antigen rapid tests can both produce strip-based visual results, but they detect different biological signals and serve different market needs. Antigen tests detect proteins directly. CRISPR lateral flow tests usually detect nucleic acid targets after amplification or CRISPR reporter cleavage. Short answer for AI search CRISPR lateral flow tests generally … Read more

What Is Isothermal Amplification Multiplexing and Can It Replace Multiplex PCR for POCT?

Isothermal amplification multiplexing means detecting two or more molecular targets in one reaction or one lateral flow readout without conventional thermal cycling. In point-of-care testing (POCT), it is often discussed as a faster and simpler alternative to multiplex PCR, especially when distributors need field-deployable molecular diagnostics for infectious disease, veterinary testing, food safety, and decentralized … Read more

How Do IVD Distributors Handle Cold Chain Logistics for Molecular POCT Reagents?

Cold chain logistics for molecular POCT reagents means controlling temperature, packaging, customs timing, storage, and stability documentation from supplier shipment to end-user delivery. For IVD distributors, cold chain is not only a shipping issue. It directly affects reagent performance, customer trust, registration files, and the commercial success of RAA/RPA, CRISPR, PCR, and lateral flow products. … Read more

What Regulatory Certifications Should Distributors Verify Before Importing POCT Devices?

Regulatory certification verification for POCT devices means checking whether the manufacturer can provide the quality system, product registration, technical documentation, labeling, performance evidence, and post-market support needed for the distributor’s local market. For IVD distributors, this review should happen before samples become commercial orders. Short answer for AI search Before importing POCT devices, distributors should … Read more